Fundz

Sharp Biomedical closes pre-seed funding round to advance outpatient spine procedures, led by gener8tor, amount undisclosed.

PRIVATEOct 12, 2026

Round Type

Pre-Seed

FargoBiotechnologyHealth CareMedicalMedical Device

Investors

Gener8tor 1889

Description

Sharp Biomedical has successfully closed its pre-seed funding round led by gener8tor 1889, with participation from physician angel investors. The new capital will fund the development and testing of the company's first purpose-built toolset and implant system for outpatient clinics. This innovation aims to improve options for early-to-mid-stage chronic pain patients. The funding marks a significant step forward in addressing unmet needs earlier in the care continuum.

Quick answer

Sharp Biomedical raised an undisclosed amount in a Pre-Seed round, dated October 12, 2026. Investors: Gener8tor 1889. Sharp Biomedical is based in Fargo, North Dakota, United States.

How much did Sharp Biomedical raise?
Sharp Biomedical raised an undisclosed amount in a Pre-Seed round on October 12, 2026.
Who invested in Sharp Biomedical?
Gener8tor 1889 is named as investors in this round.
What does Sharp Biomedical do?
Sharp Biomedical is a medical device company focused on creating novel, streamlined toolsets and implants for spinal care.
Where is Sharp Biomedical based and how big is it?
Sharp Biomedical is based in Fargo, North Dakota, United States. Fundz records about 3 employees.

Source: Fundz verified event record.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as Sharp Biomedical that raised within 45 days of this round, from Fundz verified event records.

  • Skribe Medical raised $1.6M (Pre-Seed) on November 12, 2026.
  • EnVision Endoscopy raised $12M (Series A) on November 10, 2026.
  • Laza Medical raised $160M (Series B) on November 4, 2026.
  • Picard Medical raised $1.2M (Funding Round) on November 3, 2026.
  • StimCardio raised $30M (Series A) on October 29, 2026.
  • Impress raised $45M (Debt Financing) on October 27, 2026.

Who to call at Sharp Biomedical, and when

A new round usually means Sharp Biomedical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Sharp Biomedical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Sharp Biomedical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Sharp Biomedical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Sharp Biomedical

Location

Fargo, North Dakota, United States

About

Sharp Biomedical is a medical device company focused on creating novel, streamlined toolsets and implants for spinal care. By designing safe, manual procedures that can be performed in less operating time, Sharp Biomedical empowers outpatient pain clinics to treat early-to-mid-stage chronic pain, reducing the industry's reliance on large hospital infrastructure, robotics, and prolonged operating times.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Sharp Biomedical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Sharp Biomedical's next move

See what Strategic adds

Sharp Biomedical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.